Facebook
X
LinkedIn
Forward| Title | Credit | Series date |
Member price |
Non-member price |
|---|---|---|---|---|
|
Tick Talk: Digging Deeper into Lyme Disease 2024 1.0 NAPNAP Contact Hour. This continuing education activity is free to National Association of Pediatric Nurse Practitioners (NAPNAP) members and non-members. This course is a recorded presentation for NAPNAP's 2024 National Conference. Lyme disease is the most common vector-borne disease in the U.S., with a childhood peak at five to nine years of age. Pediatric-focused APRNs in both high and low incidence areas may encounter patients in whom Lyme disease is a concern. This presentation will provide an in-depth review of Lyme disease testing and interpretation, discuss when (and when not) to treat and examine the current knowledge regarding prolonged symptoms. |
|
06/27/2024 to 06/30/2026 | $0.00 | $0.00 |
|
2025 Pediatric Pharmacology Update 1.00 NAPNAP Contact Hour of which 1.00 pharmacology content. This continuing education activity is offered as part of the 2025 Pediatric Pharmacology Bundle. This course is a recorded presentation for NAPNAP's 20255 National Conference. A fast-paced update on pediatric prescribing including newly approved or relabeled pediatric medications, and pediatric pharmacology studies in process. Issues that affect pediatric practice including drug shortages, emerging poisoning hazards, and new guidelines will be discussed. |
|
08/29/2025 to 08/31/2027 | $0.00 | $0.00 |
|
Pharmacologic Management of Cardiac Dysrhythmias 1.25 NAPNAP Contact Hour of which 1.25 pharmacology content. This continuing education activity is offered as part of the 2025 Pediatric Pharmacology Bundle. This course is a recorded presentation for NAPNAP's 20255 National Conference. This presentation will focus on the treatment of common dysrhythmias seen in children, specifically pharmacologic options. We will review both inpatient and outpatient management of various dysrhythmias. |
|
08/29/2025 to 08/31/2027 | $0.00 | $0.00 |
|
2025 Psychopharmacology Update 2.75 NAPNAP Contact Hour of which 2.75 pharmacology content, 2.75 are Psychopharmacology content and 0.25 are Controlled Substance content. This archived presentation from our 2025 national conference is available only as part of a bundle of pharmacology courses recorded during our 2025 conference in Chicago. Purchase the 2025 Pediatric Pharmacology Bundle and gain access to all five courses. Children and adolescents with behavioral health conditions are commonly seen in all pediatric environments. We will focus on the emerging use of long-acting formulations for management of chronic psychiatric conditions and other new pharmacologic approaches to behavioral health management. This presentation is solely focused on pharmacology and aims to help demystify these medications for the pediatric provider. NAPNAP’s Developmental Behavioral and Mental Health SIG is pleased to support this session. |
|
08/29/2025 to 08/31/2027 | $0.00 | $0.00 |
|
New Pediatric Antibiotic Prescribing Guidelines 1.00 NAPNAP Contact Hour of which 1.00 pharmacology content. This archived presentation from our 2025 national conference is available only as part of a bundle of pharmacology courses recorded during our 2025 conference in Chicago. Purchase the 2025 Pediatric Pharmacology Bundle and gain access to all five courses. |
|
08/29/2025 to 08/31/2027 | $0.00 | $0.00 |
|
Keeping Current in Atopic Diseases 1.25 NAPNAP Contact Hour of which 1.25 pharmacology content. This continuing education activity is offered as part of the 2025 Pediatric Pharmacology Bundle. This course is a recorded presentation for NAPNAP's 20255 National Conference. The field of Allergy & Immunology continues to expand and incorporate new therapeutics to manage difficult diseases. In 2024, new drugs have been approved that can revolutionize treatment for disease management. Patients will look to their primary care clinicians to be knowledgeable and a resource for these therapeutics. This panel will include three NP experts from food allergy centers at the Children’s Hospital of Philadelphia and University of Texas Southwestern and will discuss biologics, immunotherapy options and non-IgE mediated disease updates for food allergy. NAPNAP’s Asthma and Allergy SIG is pleased to support this session. |
|
08/29/2025 to 08/31/2027 | $0.00 | $0.00 |
|
TikTok Toxidromes: Review of Overdose Trends in Adolescents Free January PedsCE Course - Exclusive benefit for NAPNAP members 1.00 NAPNAP Contact Hour of which 1.00 pharmacology content, 0.25 Psychopharmacology content and 0.25 Controlled Substance content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non-members, this continuing education activity rate is $20. This course is a recorded presentation for NAPNAP's 2025 National Conference. Overdoses, whether intentional or unintentional, were the second leading cause of death in adolescents aged 12-19 from 2018-2022, surpassed over by gun violence. Social media "challenges" often influence the type of substances ingested. This presentation will review current ingestion trends using case studies, ensuring that participants are prepared to identify and treat the sequelae of these toxidromes. NAPNAP’s Adolescent Health Care SIG is pleased to support this session. |
|
06/30/2025 to 06/30/2027 | $0.00 | $20.00 |
|
JPHC CE: Patellofemoral Pain Syndrome in Adolescents: Continuing Education for the Primary Care Provider 1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Patellofemoral Pain Syndrome (PFPS) is a multifactorial complaint of anterior knee pain. Patellofemoral pain typically spreads diffusely across the knee, is notable during weight bearing, and is exacerbated by knee flexion. Patellofemoral pain is often insidious in onset, typically with no identifiable mechanism of injury. Factors believed to contribute to PFPS include overuse, muscular imbalance, joint malalignment, and, rarely, trauma to the joint (Bump & Lewis, 2023). J Pediatr Health Care (2025) 39, 686-694. |
|
07/01/2025 to 08/31/2026 | $0.00 | $10.00 |
|
JPHC CE: Trauma Exposure in Migrant Children: Implications for Mental and Physical Health 1.5 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Global migration is a public health crisis of epidemic proportions. Migrants are at risk for a variety of physical and mental health concerns, while having limited access to healthcare. Migrant children are especially vulnerable to experiencing significant trauma, both physical and emotional. Children comprise less than one third of the global population, yet nearly half of migrants are children less than 18 years of age. The United States is home to a significant number of migrant children. Migrant children have a unique set of educational, health, and emotional needs. Given the sheer number of migrant children living in the U.S., pediatric nurse practitioners (PNP) must understand their unique needs and provide evidence-based interventions to help meet these needs. This continuing education article will discuss migrant children in terms of understanding migration, trauma exposure and resultant impact on psychological and physical health, and implications for practice. J Pediatr Health Care (2025) 40, 1-12. |
|
09/01/2025 to 10/31/2026 | $0.00 | $10.00 |
|
JPHC CE: The Landscape of Substance Use in Youth-2024 1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. An essential role of pediatric providers is to counsel youth and parents on behavioral health issues, including the use of Alcohol or other drugs (AODs). Although substance use by adolescents has decreased, a significant number of adolescents use AODs, causing those with regular use to be at risk of developing behavioral, physical, and mental health consequences that can continue into adulthood. This article was written to help pediatric providers understand the scope and associated effects of AOD use in their adolescent patients and equip them to counsel, identify, and intervene to reduce the harm to their patients who use AODs. J Pediatr Health Care (2025) Issue 6, p1-12. |
|
11/01/2025 to 12/31/2026 | $0.00 | $10.00 |
|
Influenza 2025-2026: Is Your Pediatric Practice Ready? 1.0 NAPNAP Contact Hour of which 0.75 contain pharmacology content. This continuing education activity is offered free for NAPNAP Members and non-members. As we enter influenza season, pediatric-focused APRNs can increase their knowledge and prepare to counsel families and restore confidence in influenza vaccines. This continuing education presentation will teach providers to balance communication of scientific data and vaccine efficacy with acknowledgment of parental concerns and fears, and help families feel empowered to make the best decisions when it comes to flu prevention. |
|
11/14/2025 to 11/30/2026 | $0.00 | $0.00 |
|
Leucovorin in Autism: An Evidence-Based and Clinically Informed Approach 1.25 NAPNAP Contact Hours of which 1.25 contains pharmacology content. This continuing education activity is offered free for NAPNAP Members and non-members. This presentation synthesizes the evidence on folinic acid in autism, with an emphasis on advances since 2018 within the context of foundational work. We will examine the pathophysiology of cerebral folate deficiency (CFD), clarify genetic contributors (e.g., FOLR1 and folate-pathway variants), and review clinical testing with folate receptor-α autoantibodies and related labs. Practical treatment guidance will cover formulation selection, dosing and titration, monitoring, adverse effects, and pharmacy/compounding and cost considerations. Taught by a clinician with extensive real-world experience, the presentation highlights where the evidence is strongest and how to implement it. Learners will finish with a concise, evidence-based framework for evaluating and managing CFD in autism within standard practice. |
|
11/12/2025 to 11/30/2027 | $0.00 | $0.00 |
|
JPHC CE: Sexting and Sextortion in Adolescents: Essentials for the PNP 1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Sexting and sextortion are increasingly common concerns among adolescents, presenting significant challenges for pediatric nurse practitioners (PNPs). Sexting, or digital sharing of self-produced nude or otherwise sexual images, is increasingly seen as a normative part of adolescent sexual exploration, but carries substantial risks, particularly when images are shared non-consensually, by minors, or used as a method of bullying or extortion (“sextortion”). PNPs play a critical role in early identification of any nonconsensual texting and by providing education to adolescents so they may explore their sexuality safely, resist peer pressure, and maintain boundaries. J Pediatr Health Care (2026) 40, Issue 1, P162-173. |
|
01/01/2026 to 02/28/2027 | $0.00 | $10.00 |
|
JPHC CE: Monitoring Vaccine Safety: United States Vaccine Safety Surveillance Systems 1.0 NAPNAP contact hour of which contain 1.0 pharmacology content. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Immunization is an effective public health tool to protect children from hospitalization and death from vaccine-preventable diseases. Vaccine safety monitoring is essential to understand risks of vaccination. The Centers for Disease Control and Prevention closely monitors vaccine safety through multiple surveillance systems, including V-safe, the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. This paper briefly discusses each surveillance system and available evidence that healthcare providers can use to respond to common vaccine concerns. As trusted sources of information about vaccines, pediatric nurses and nurse practitioners need to understand how vaccine safety is monitored, where to access reliable resources about vaccines, and when and where to report adverse events noted after vaccination. J Pediatr Health Care (2026) 40, Issue 1, P174-186. |
|
01/01/2026 to 02/28/2027 | $0.00 | $10.00 |